NCT02480621View on ClinicalTrials.gov

Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF)

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Ankle Fracture
Interventions
DRUG

Liposomal Bupivacaine with Bupivacaine

Pain medications injected locally during surgery around affected ankle.

Trial Locations (1)

11418

Jamaica Hospital Medical Center, Jamaica

All Listed Sponsors
lead

Jamaica Hospital Medical Center

OTHER

NCT02480621 - Liposomal Bupivacaine With Bupivacaine in Ankle Fracture Open Reduction Internal Fixation (ORIF) | Biotech Hunter | Biotech Hunter